129 related articles for article (PubMed ID: 36584481)
1. Stabilizing cardiac ryanodine receptor with dantrolene treatment prevents left ventricular remodeling in pressure-overloaded heart failure mice.
Yano Y; Kobayashi S; Uchida T; Chang Y; Nawata J; Fujii S; Nakamura Y; Suetomi T; Uchinoumi H; Oda T; Yamamoto T; Yano M
Biochem Biophys Res Commun; 2023 Jan; 642():175-184. PubMed ID: 36584481
[TBL] [Abstract][Full Text] [Related]
2. RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
Fujii S; Kobayashi S; Chang Y; Nawata J; Yoshitomi R; Tanaka S; Kohno M; Nakamura Y; Ishiguchi H; Suetomi T; Uchinoumi H; Oda T; Okuda S; Okamura T; Yamamoto T; Yano M
J Mol Cell Cardiol; 2023 May; 178():36-50. PubMed ID: 36963751
[TBL] [Abstract][Full Text] [Related]
3. Stabilizing cardiac ryanodine receptor prevents the development of cardiac dysfunction and lethal arrhythmia in Ca
Sufu-Shimizu Y; Okuda S; Kato T; Nishimura S; Uchinoumi H; Oda T; Kobayashi S; Yamamoto T; Yano M
Biochem Biophys Res Commun; 2020 Apr; 524(2):431-438. PubMed ID: 32007269
[TBL] [Abstract][Full Text] [Related]
4. Subclinical abnormalities in sarcoplasmic reticulum Ca(2+) release promote eccentric myocardial remodeling and pump failure death in response to pressure overload.
Sedej S; Schmidt A; Denegri M; Walther S; Matovina M; Arnstein G; Gutschi EM; Windhager I; Ljubojević S; Negri S; Heinzel FR; Bisping E; Vos MA; Napolitano C; Priori SG; Kockskämper J; Pieske B
J Am Coll Cardiol; 2014 Apr; 63(15):1569-79. PubMed ID: 24315909
[TBL] [Abstract][Full Text] [Related]
5. Correction of impaired calmodulin binding to RyR2 as a novel therapy for lethal arrhythmia in the pressure-overloaded heart failure.
Kato T; Yamamoto T; Nakamura Y; Nanno T; Fukui G; Sufu Y; Hamada Y; Maeda T; Nishimura S; Ishiguchi H; Murakami W; Fukuda M; Xu X; Hino A; Ono M; Oda T; Okuda S; Kobayashi S; Koseki N; Kyushiki H; Yano M
Heart Rhythm; 2017 Jan; 14(1):120-127. PubMed ID: 27771553
[TBL] [Abstract][Full Text] [Related]
6. Dantrolene prevents ventricular tachycardia by stabilizing the ryanodine receptor in pressure- overload induced failing hearts.
Kajii T; Kobayashi S; Shiba S; Fujii S; Tamitani M; Kohno M; Nakamura Y; Nanno T; Kato T; Okuda S; Uchinoumi H; Oda T; Yamamoto T; Yano M
Biochem Biophys Res Commun; 2020 Jan; 521(1):57-63. PubMed ID: 31635807
[TBL] [Abstract][Full Text] [Related]
7. CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift.
Uchinoumi H; Yang Y; Oda T; Li N; Alsina KM; Puglisi JL; Chen-Izu Y; Cornea RL; Wehrens XHT; Bers DM
J Mol Cell Cardiol; 2016 Sep; 98():62-72. PubMed ID: 27318036
[TBL] [Abstract][Full Text] [Related]
8. Cardiac hypertrophy associated with impaired regulation of cardiac ryanodine receptor by calmodulin and S100A1.
Yamaguchi N; Chakraborty A; Huang TQ; Xu L; Gomez AC; Pasek DA; Meissner G
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H86-94. PubMed ID: 23666671
[TBL] [Abstract][Full Text] [Related]
9. RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease.
Schmeckpeper J; Kim K; George SA; Blackwell DJ; Brennan JA; Efimov IR; Knollmann BC
J Mol Cell Cardiol; 2023 Aug; 181():67-78. PubMed ID: 37285929
[TBL] [Abstract][Full Text] [Related]
10. Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin.
Oda T; Yamamoto T; Kato T; Uchinoumi H; Fukui G; Hamada Y; Nanno T; Ishiguchi H; Nakamura Y; Okamoto Y; Kono M; Okuda S; Kobayashi S; Bers DM; Yano M
J Mol Cell Cardiol; 2018 Dec; 125():87-97. PubMed ID: 30359562
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure.
Ono M; Yano M; Hino A; Suetomi T; Xu X; Susa T; Uchinoumi H; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Koseki N; Kyushiki H; Ikemoto N; Matsuzaki M
Cardiovasc Res; 2010 Sep; 87(4):609-17. PubMed ID: 20388639
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of ryanodine receptor (RyR) and calmodulin enhance Ca release and pathologically alter, RyR structure and calmodulin affinity.
Oda T; Yang Y; Uchinoumi H; Thomas DD; Chen-Izu Y; Kato T; Yamamoto T; Yano M; Cornea RL; Bers DM
J Mol Cell Cardiol; 2015 Aug; 85():240-8. PubMed ID: 26092277
[TBL] [Abstract][Full Text] [Related]
13. Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action.
Ashna A; van Helden DF; Dos Remedios C; Molenaar P; Laver DR
Mol Pharmacol; 2020 Apr; 97(4):250-258. PubMed ID: 32015008
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of calmodulin regulation of RyR2 in controlling heart rhythm, the progression of heart failure and the antiarrhythmic action of dantrolene.
Walweel K; Oo YW; Laver DR
Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):135-142. PubMed ID: 27626620
[TBL] [Abstract][Full Text] [Related]
15. Dantrolene rescues aberrant N-terminus intersubunit interactions in mutant pro-arrhythmic cardiac ryanodine receptors.
Seidel M; Thomas NL; Williams AJ; Lai FA; Zissimopoulos S
Cardiovasc Res; 2015 Jan; 105(1):118-28. PubMed ID: 25411383
[TBL] [Abstract][Full Text] [Related]
16. FKBP12.6 mice display temporal gender differences in cardiac Ca(2+)-signalling phenotype upon chronic pressure overload.
Prévilon M; Pezet M; Semprez F; Mercadier JJ; Rouet-Benzineb P
Can J Physiol Pharmacol; 2011 Nov; 89(11):769-82. PubMed ID: 22007848
[TBL] [Abstract][Full Text] [Related]
17. Limitations of FKBP12.6-directed treatment strategies for maladaptive cardiac remodeling and heart failure.
Seidler T; Teucher N; Hellenkamp K; Unsöld B; Grebe C; Kramps P; Schotola H; Wagner S; Schöndube FA; Hasenfuss G; Maier LS
J Mol Cell Cardiol; 2011 Jan; 50(1):33-42. PubMed ID: 20797399
[TBL] [Abstract][Full Text] [Related]
18. Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure.
Yang Y; Guo T; Oda T; Chakraborty A; Chen L; Uchinoumi H; Knowlton AA; Fruen BR; Cornea RL; Meissner G; Bers DM
Circ Res; 2014 Jan; 114(2):295-306. PubMed ID: 24186966
[TBL] [Abstract][Full Text] [Related]
19. Dantrolene improves left ventricular diastolic property in mineralcorticoid-salt-induced hypertensive rats.
Nawata J; Yamamoto T; Tanaka S; Yano Y; Uchida T; Fujii S; Nakamura Y; Suetomi T; Uchinoumi H; Oda T; Kobayashi S; Yano M
Biochem Biophys Rep; 2023 Jul; 34():101449. PubMed ID: 36926278
[TBL] [Abstract][Full Text] [Related]
20. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction.
Xu X; Yano M; Uchinoumi H; Hino A; Suetomi T; Ono M; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ikemoto N; Matsuzaki M
Biochem Biophys Res Commun; 2010 Apr; 394(3):660-6. PubMed ID: 20226167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
